Benzalkonium chloride causes colposcopic changes and increased susceptibility to genital herpes infection in mice

Kathleen Vincent, Brent A. Bell, Rebecca K. Johnston, Rachael Stegall, Gracie Vargas, Alai Tan, Lawrence R. Stanberry, Susan L. Rosenthal, Gregg Milligan, Massoud Motamedi, Nigel Bourne

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Colposcopy is widely used in clinical microbicide safety testing but not in preclinical small animal studies. Endoscopic colposcopy could be employed in small animals allowing colposcopy to be used as one component in a multifactorial safety testing paradigm. Study design: We conducted dose-response studies in mice using 2%, 0.2%, or 0.02% benzalkonium chloride (BZK) as the test compound, and using multiple safety end points that included endoscopic colposcopy, susceptibility to vaginal HSV-2 infection, histology, and entry of inflammatory cells into the vagina. Results: Animals treated with 0.2% or higher BZK experienced vaginal toxicities detectable by all tests used including colposcopy. In contrast, 0.02% BZK produced no significant changes except by histology in which a significant thinning of the vaginal epithelium was seen. Conclusion: Endoscopic colposcopy detected microbicide-elicited changes in the mouse vagina with similar sensitivity to the other endpoints used in these studies and would appear to be useful as part of a multifactorial microbicide safety testing paradigm in mice.

Original languageEnglish (US)
Pages (from-to)579-584
Number of pages6
JournalSexually Transmitted Diseases
Volume37
Issue number9
DOIs
StatePublished - Sep 2010

Fingerprint

Benzalkonium Compounds
Herpes Genitalis
Colposcopy
Anti-Infective Agents
Infection
Safety
Vagina
Histology
Human Herpesvirus 2
Epithelium

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Benzalkonium chloride causes colposcopic changes and increased susceptibility to genital herpes infection in mice. / Vincent, Kathleen; Bell, Brent A.; Johnston, Rebecca K.; Stegall, Rachael; Vargas, Gracie; Tan, Alai; Stanberry, Lawrence R.; Rosenthal, Susan L.; Milligan, Gregg; Motamedi, Massoud; Bourne, Nigel.

In: Sexually Transmitted Diseases, Vol. 37, No. 9, 09.2010, p. 579-584.

Research output: Contribution to journalArticle

Vincent, Kathleen ; Bell, Brent A. ; Johnston, Rebecca K. ; Stegall, Rachael ; Vargas, Gracie ; Tan, Alai ; Stanberry, Lawrence R. ; Rosenthal, Susan L. ; Milligan, Gregg ; Motamedi, Massoud ; Bourne, Nigel. / Benzalkonium chloride causes colposcopic changes and increased susceptibility to genital herpes infection in mice. In: Sexually Transmitted Diseases. 2010 ; Vol. 37, No. 9. pp. 579-584.
@article{c343220e7f204f69a91b5f4393506fc2,
title = "Benzalkonium chloride causes colposcopic changes and increased susceptibility to genital herpes infection in mice",
abstract = "Background: Colposcopy is widely used in clinical microbicide safety testing but not in preclinical small animal studies. Endoscopic colposcopy could be employed in small animals allowing colposcopy to be used as one component in a multifactorial safety testing paradigm. Study design: We conducted dose-response studies in mice using 2{\%}, 0.2{\%}, or 0.02{\%} benzalkonium chloride (BZK) as the test compound, and using multiple safety end points that included endoscopic colposcopy, susceptibility to vaginal HSV-2 infection, histology, and entry of inflammatory cells into the vagina. Results: Animals treated with 0.2{\%} or higher BZK experienced vaginal toxicities detectable by all tests used including colposcopy. In contrast, 0.02{\%} BZK produced no significant changes except by histology in which a significant thinning of the vaginal epithelium was seen. Conclusion: Endoscopic colposcopy detected microbicide-elicited changes in the mouse vagina with similar sensitivity to the other endpoints used in these studies and would appear to be useful as part of a multifactorial microbicide safety testing paradigm in mice.",
author = "Kathleen Vincent and Bell, {Brent A.} and Johnston, {Rebecca K.} and Rachael Stegall and Gracie Vargas and Alai Tan and Stanberry, {Lawrence R.} and Rosenthal, {Susan L.} and Gregg Milligan and Massoud Motamedi and Nigel Bourne",
year = "2010",
month = "9",
doi = "10.1097/OLQ.0b013e3181dac410",
language = "English (US)",
volume = "37",
pages = "579--584",
journal = "Sexually Transmitted Diseases",
issn = "0148-5717",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Benzalkonium chloride causes colposcopic changes and increased susceptibility to genital herpes infection in mice

AU - Vincent, Kathleen

AU - Bell, Brent A.

AU - Johnston, Rebecca K.

AU - Stegall, Rachael

AU - Vargas, Gracie

AU - Tan, Alai

AU - Stanberry, Lawrence R.

AU - Rosenthal, Susan L.

AU - Milligan, Gregg

AU - Motamedi, Massoud

AU - Bourne, Nigel

PY - 2010/9

Y1 - 2010/9

N2 - Background: Colposcopy is widely used in clinical microbicide safety testing but not in preclinical small animal studies. Endoscopic colposcopy could be employed in small animals allowing colposcopy to be used as one component in a multifactorial safety testing paradigm. Study design: We conducted dose-response studies in mice using 2%, 0.2%, or 0.02% benzalkonium chloride (BZK) as the test compound, and using multiple safety end points that included endoscopic colposcopy, susceptibility to vaginal HSV-2 infection, histology, and entry of inflammatory cells into the vagina. Results: Animals treated with 0.2% or higher BZK experienced vaginal toxicities detectable by all tests used including colposcopy. In contrast, 0.02% BZK produced no significant changes except by histology in which a significant thinning of the vaginal epithelium was seen. Conclusion: Endoscopic colposcopy detected microbicide-elicited changes in the mouse vagina with similar sensitivity to the other endpoints used in these studies and would appear to be useful as part of a multifactorial microbicide safety testing paradigm in mice.

AB - Background: Colposcopy is widely used in clinical microbicide safety testing but not in preclinical small animal studies. Endoscopic colposcopy could be employed in small animals allowing colposcopy to be used as one component in a multifactorial safety testing paradigm. Study design: We conducted dose-response studies in mice using 2%, 0.2%, or 0.02% benzalkonium chloride (BZK) as the test compound, and using multiple safety end points that included endoscopic colposcopy, susceptibility to vaginal HSV-2 infection, histology, and entry of inflammatory cells into the vagina. Results: Animals treated with 0.2% or higher BZK experienced vaginal toxicities detectable by all tests used including colposcopy. In contrast, 0.02% BZK produced no significant changes except by histology in which a significant thinning of the vaginal epithelium was seen. Conclusion: Endoscopic colposcopy detected microbicide-elicited changes in the mouse vagina with similar sensitivity to the other endpoints used in these studies and would appear to be useful as part of a multifactorial microbicide safety testing paradigm in mice.

UR - http://www.scopus.com/inward/record.url?scp=77955899471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955899471&partnerID=8YFLogxK

U2 - 10.1097/OLQ.0b013e3181dac410

DO - 10.1097/OLQ.0b013e3181dac410

M3 - Article

VL - 37

SP - 579

EP - 584

JO - Sexually Transmitted Diseases

JF - Sexually Transmitted Diseases

SN - 0148-5717

IS - 9

ER -